Tofacitinib
id:
tofacitinib-162-5739641
title:
Tofacitinib
text:
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis. It is a janus kinase (JAK) inhibitor, discovered and developed by the National Institutes of Health and Pfizer. Common side effects include diarrhea, headache, and high blood pressure. Serious side effects may include infections, cancer, and pulmonary embolism. In 2019,
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Tofacitinib
date created:
2011-02-09T12:58:43Z
date modified:
2024-08-28T07:00:53Z
main entity:
{"identifier":"Q3530324","url":"https://www.wikidata.org/entity/Q3530324"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/07/Tofacitinib.svg","width":512,"height":347}
fields total:
13
integrity:
16